These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36995383)

  • 1. The link between increased Desulfovibrio and disease severity in Parkinson's disease.
    Nie S; Jing Z; Wang J; Deng Y; Zhang Y; Ye Z; Ge Y
    Appl Microbiol Biotechnol; 2023 May; 107(9):3033-3045. PubMed ID: 36995383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory microbes and genes as potential biomarkers of Parkinson's disease.
    Nie S; Wang J; Deng Y; Ye Z; Ge Y
    NPJ Biofilms Microbiomes; 2022 Dec; 8(1):101. PubMed ID: 36564391
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Murros KE; Huynh VA; Takala TM; Saris PEJ
    Front Cell Infect Microbiol; 2021; 11():652617. PubMed ID: 34012926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
    Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
    Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study.
    Wang Y; Zhang Y; Lane NE; Wu J; Yang T; Li J; He H; Wei J; Zeng C; Lei G
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2340-2351. PubMed ID: 35851765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome in Parkinson's disease: New insights from meta-analysis.
    Toh TS; Chong CW; Lim SY; Bowman J; Cirstea M; Lin CH; Chen CC; Appel-Cresswell S; Finlay BB; Tan AH
    Parkinsonism Relat Disord; 2022 Jan; 94():1-9. PubMed ID: 34844021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome.
    Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK
    Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of hydrogen sulfide toward sulfate-reducing bacteria Desulfovibrio piger Vib-7.
    Kushkevych I; Dordević D; Vítězová M
    Arch Microbiol; 2019 Apr; 201(3):389-397. PubMed ID: 30707247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Sectional Study on the Gut Microbiome of Parkinson's Disease Patients in Central China.
    Mao L; Zhang Y; Tian J; Sang M; Zhang G; Zhou Y; Wang P
    Front Microbiol; 2021; 12():728479. PubMed ID: 34650532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease.
    Shi J; Wang Y; Chen D; Xu X; Li W; Li K; He J; Su W; Luo Q
    Appl Microbiol Biotechnol; 2023 Mar; 107(5-6):1917-1929. PubMed ID: 36795141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desulfovibrio marinisediminis sp. nov., a novel sulfate-reducing bacterium isolated from coastal marine sediment via enrichment with Casamino acids.
    Takii S; Hanada S; Hase Y; Tamaki H; Uyeno Y; Sekiguchi Y; Matsuura K
    Int J Syst Evol Microbiol; 2008 Oct; 58(Pt 10):2433-8. PubMed ID: 18842870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide Produced by Gut Bacteria May Induce Parkinson's Disease.
    Murros KE
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations of gut microbiota and metabolome with Parkinson's disease.
    Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
    Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of short-term changes in dietary sulfur on the relative abundances of intestinal sulfate-reducing bacteria.
    Dostal Webster A; Staley C; Hamilton MJ; Huang M; Fryxell K; Erickson R; Kabage AJ; Sadowsky MJ; Khoruts A
    Gut Microbes; 2019; 10(4):447-457. PubMed ID: 30810441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.